Page No 1 2 3 4 |
Phrase | Consultant | Town | Special Interests |
Clinical Pharmacology | *Consultant(s)* | *Towns* | Therapeutics, general internal medicine |
clinical pharmacology | *Consultant(s)* | *Towns* | HIV, clinical pharmacology |
clinical pharmacology | *Consultant(s)* | *Towns* | Adverse drug reactions, pharmacogenetics, clinical pharmacology |
clinical pharmacology and therapeutics | *Consultant(s)* | *Towns* | General internal medicine, clinical pharmacology and therapeutics |
clinical pharmacology and therapeutics | *Consultant(s)* | *Towns* | Acute medicine, clinical pharmacology and therapeutics |
clinical pharmacology of pain | *Consultant(s)* | *Towns* | Neuropathic pain, clinical pharmacology of pain, botox for peripheral neuropathic pain, high dose capsaicin patches, spinal cord and peripheral nerve stimulation for peripheral neuropathic pain, repetitive transcranial magnetic stimulation, opioid management, fibromyalgia |
clinical risk management | *Consultant(s)* | *Towns* | Labour ward management, pelvic surgery, feto-maternal medicine, minimal access surgery, vaginal surgery, high risk obstetrics, benign gynaecology, clinical risk management |
Clinical risk management | *Consultant(s)* | *Towns* | Clinical risk management, teaching, medical law |
clinical service development | *Consultant(s)* | *Towns* | Neurointensive care, strategic planning for healthcare, health system integration, clinical service development |
clinical therapies | *Consultant(s)* | *Towns* | Stroke medicine, falls, syncope, clinical therapies, acute medicine, difficult hypertension |
clinical trial design and reporting | *Consultant(s)* | *Towns* | Interventional cardiology, stenting, angioplasty, clinical trial design and reporting, alcohol ablation in hypertrophic obstructive cardiomyopathy, transcatheter aortic valve implantation - TAVI |
core and swallowing outcomes in late phase clinical trials involving patients with OPSCC - oropharyngeal squamous cell carcinoma | *Consultant(s)* | *Towns* | Early phase clinical trials, the role of the p53/MDM2 pathway in radioresistance and cellular motility, the therapeutic exploitation of the unfolded protein response in head and neck cancer, treatment response in HPV - human papilloma virus +ve oropharyngeal cancer intraoperative radiotherapy, core and swallowing outcomes in late phase clinical trials involving patients with OPSCC - oropharyngeal squamous cell carcinoma, function sparing surgical strategies for head and neck cancer - especially transoral laser microsurgery |
development of early phase clinical trials of anti-cancer therapies | *Consultant(s)* | *Towns* | Medical oncology, development of early phase clinical trials of anti-cancer therapies |
Early phase clinical trials | *Consultant(s)* | *Towns* | Early phase clinical trials, the role of the p53/MDM2 pathway in radioresistance and cellular motility, the therapeutic exploitation of the unfolded protein response in head and neck cancer, treatment response in HPV - human papilloma virus +ve oropharyngeal cancer intraoperative radiotherapy, core and swallowing outcomes in late phase clinical trials involving patients with OPSCC - oropharyngeal squamous cell carcinoma, function sparing surgical strategies for head and neck cancer - especially transoral laser microsurgery |
early phase clinical trials | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, head and neck cancer, early phase clinical trials, immunotherapy |
Expert in clinical negligence | *Consultant(s)* | *Towns* | Expert in clinical negligence |
general clinical biochemistry | *Consultant(s)* | *Towns* | Lipids and cardiovascular risk management, specialist obesity management, general clinical biochemistry, diabetes, medical education |
medical director clinical and scientific services | *Consultant(s)* | *Towns* | Gastrointestinal imaging, nonvascular interventional radiology, radiology of weight reduction therapies including gastric band adjustment, medical director clinical and scientific services |
Page No 1 2 3 4 |